Cepheid
Lynn Beatty is an experienced professional currently serving as the Director of National Accounts at Cepheid since August 2021, focusing on strategic engagement with large national integrated delivery networks to develop partnerships and contracts for innovative healthcare solutions. With a robust background in leadership roles within the National Black MBA Association and a proven track record in sales strategy development at GE Healthcare, Lynn has made significant contributions in various capacities, including operations management at Cedars-Sinai Medical Center and general management roles at Accredo Health and CliniShare. Lynn holds an MBA in Sales & Management from Loyola Marymount University and a BS in Registered Nursing from California State University, Long Beach.
This person is not in any teams
This person is not in any offices
Cepheid
10 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.